Granite Shares Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Granite Shares Advisors LLC

$145 Million
Q3 2024

A detailed history of Granite Shares Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Granite Shares Advisors LLC holds 1,109 shares of REGN stock, worth $820,671. This represents 0.8% of its overall portfolio holdings.

Number of Shares

1,109

Previous 1,230 9.84%

Holding current value

$820,671

Previous $1.29 Million 9.83%

% of portfolio

0.8%

Previous 0.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$1024.09 - $1201.76 $123,914 - $145,412	-121 Reduced 9.84%	1,109 $1.17 Million
Q2 2024 Aug 01, 2024	BUY	$883.2 - $1071.19 $90,086 - $109,261	102 Added 9.04%	1,230 $1.29 Million
Q1 2024 Apr 22, 2024	SELL	$902.69 - $993.35 $8,124 - $8,940	-9 Reduced 0.79%	1,128 $1.09 Million
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $136,431 - $155,179	-176 Reduced 13.4%	1,137 $998,000
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $695,219 - $847,747	1,004 Added 324.92%	1,313 $1.08 Million
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $14,700 - $17,437	-21 Reduced 6.36%	309 $222,000
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $5,443 - $6,615	-8 Reduced 2.37%	330 $271,000
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $40,235 - $43,684	-57 Reduced 14.43%	338 $0
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $30,994 - $39,113	-54 Reduced 12.03%	395 $272,000
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $7,128 - $9,604	-13 Reduced 2.81%	449 $265,000
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $29,160 - $34,223	-49 Reduced 9.59%	462 $322,000
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $277,718 - $342,865	511 New	511 $322,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.

Account

Granite Shares Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History